
Swiss organization will take patient-centric approach towards developing injectables
Company’s prospective malaria and tuberculosis doses will be developed in Rwanda, Senegal
Irvine, CA, location will house 40,000 square feet of oral solid dosage forms
Agreement will focus on developing, manufacturing and commercializing biosimilars in the respiratory space
Meeting future expectations in pharmaceutical sustainability a key component of shipping collaboration
Project will center on equipment and technology improvements, says UK R&D and manufacturing accelerator
Healthcare tech company acquires Medical Marketing Economics, a provider of value-based strategy support
The latest people news happenings over the past month
Gene therapy tech collaboration will target treatment development for Alzheimer's, Parkinson's and rare diseases
Wholesaler's 3PL arm to provide logistics and distribution support to potential emergency use drug for patients with critical Covid with respiratory failure
Swiss CDMO’s expansion at recently opened Guangzhou plant expected to be ready by next year
CAGR growth through 2026 will be 6.4% per year
Deal for CHC Health adds depth, scale and expanded clinical expertise in health outcomes pursuits
Venture anticipated to more than double single-use bioreactor mammalian cell-culture capacity on site
Agency hopes Pfizer-BioNTech jab approval will convince some in public to get vaccinated
CDMO's expansion of Rensselaer, NY, facility will help grow its API division
Acquisition addresses the need for meeting healthcare sector’s patient support demand
Cardiff center will help produce lipids that are necessary for mRNA Covid vaccines
Developments include the creation of a new microbial facility, expansion of mammalian center
Deal allows for bicoastal expansion of pharmaceutical services
Plan aims to offset costs associated with proposed social and health initiatives
Company is also cited by SAP; meanwhile, HDA attendees get cautioned by FDA
Announcement only applies to mRNA doses at this point
End result is an enhanced method for developing vaccinia capping enzyme (VCE), parties say
CDMO’s future greater Boston facility to expand cGMP manufacturing capacity, accelerate commercial drug supply
Manufacturing center expected to integrate data analytics, machine learning into production process
Marks the fifth shot to receive emergency approval by Indian health authorities
Sets the scene for a messenger RNA production facility in Canada
Michigan site adds 110,000 square feet to its production footprint as company aims to meet additional demand